Q2 2026 · 13F-HR
Andera Partnersholdings as filed
Filed 2026-07-22 · accession 0001757283-26-000015
$206.5M
Reported value
8
Positions
2026-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G52441105 | KMTS | KESTRA MED TECHNOLOGIES LTD | $69.4M | 33.6% | 2,728,679 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $42.9M | 20.8% | 1,591,917 | Common | SOLE |
| 05348Y105 | AVLN | AVALYN PHARMACEUTICALS INC | $30.6M | 14.8% | 929,824 | Common | SOLE |
| 00860C102 | AGMB | AGOMAB THERAPEUTICS NV | $20.0M | 9.67% | 1,538,702 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $18.5M | 8.96% | 1,391,990 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $13.7M | 6.65% | 3,633,181 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $10.4M | 5.04% | 78,125 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $882,276 | 0.43% | 522,057 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.